Overview

Treatment of Cancer-associated Anorexia Using Megestrol Acetate Concentrated Suspension

Status:
Terminated
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
To compare the effect of megestrol acetate concentrated suspension and placebo on caloric intake in patients with cancer-associated anorexia.
Phase:
Phase 3
Details
Lead Sponsor:
Par Pharmaceutical, Inc.
Collaborator:
PRA Health Sciences
Treatments:
Megestrol
Megestrol Acetate